StockData
GTHPOTCElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31

GUIDED THERAPEUTICS INC

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026
$0.16−0.03 (-15.79%)

Close on Oct 19, 2026

Market cap
$15.45M
P/E (TTM)
–
Dividend yield
–

Earnings

Quarterly results announced on Form 8-K, Item 2.02

QuarterReportedTimeRevenueEPS (GAAP)EPS (adjusted)
Q2 FY2016
Ended Jun 30, 2016
Aug 18, 2016Before market open–––
Q1 FY2016
Ended Mar 31, 2016
May 19, 2016Before market open–––
Q4 FY2015
Ended Dec 31, 2015
Mar 15, 2016During market hours–––
Q3 FY2015
Ended Sep 30, 2015
Nov 13, 2015During market hours–––
Q2 FY2015
Ended Jun 30, 2015
Aug 13, 2015During market hours–––
Q1 FY2015
Ended Mar 31, 2015
May 14, 2015During market hours–––
Q4 FY2014
Ended Dec 31, 2014
Mar 30, 2015During market hours–––
Q3 FY2014
Ended Sep 30, 2014
Nov 14, 2014During market hours–––
Q2 FY2014
Ended Jun 30, 2014
Aug 14, 2014During market hours–––
Q1 FY2014
Ended Mar 31, 2014
May 19, 2014Before market open–––
Q4 FY2013
Ended Dec 31, 2013
Mar 27, 2014During market hours–––
Q3 FY2013
Ended Sep 30, 2013
Nov 15, 2013During market hours–––

Press releases

Announcements Guided Therapeutics filed with the SEC